These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 14743202)

  • 21. Epigenetic and genetic alterations of p33ING1b in ovarian cancer.
    Shen DH; Chan KY; Khoo US; Ngan HY; Xue WC; Chiu PM; Ip P; Cheung AN
    Carcinogenesis; 2005 Apr; 26(4):855-63. PubMed ID: 15677627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and regulation of tumor suppressor gene maspin in human bladder cancer.
    Sugimoto S; Maass N; Takimoto Y; Sato K; Minei S; Zhang M; Hoshikawa Y; Jünemann KP; Jonat W; Nagasaki K
    Cancer Lett; 2004 Jan; 203(2):209-15. PubMed ID: 14732229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
    Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
    J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
    Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
    Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylation-induced silencing of maspin contributes to the proliferation of human glioma cells.
    Xu L; Liu H; Yu J; Wang Z; Zhu Q; Li Z; Zhong Q; Zhang S; Qu M; Lan Q
    Oncol Rep; 2016 Jul; 36(1):57-64. PubMed ID: 27177016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic silencing of maspin expression occurs early in the conversion of keratocytes to fibroblasts.
    Horswill MA; Narayan M; Warejcka DJ; Cirillo LA; Twining SS
    Exp Eye Res; 2008 Apr; 86(4):586-600. PubMed ID: 18291368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maspin in thyroid cancer: its relationship with p53 and clinical outcome.
    Boltze C; Schneider-Stock R; Meyer F; Peters B; Quednow C; Hoang-Vu C; Roessner A
    Oncol Rep; 2003; 10(6):1783-7. PubMed ID: 14534696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human pancreatic carcinoma cells activate maspin expression through loss of epigenetic control.
    Fitzgerald M; Oshiro M; Holtan N; Krager K; Cullen JJ; Futscher BW; Domann FE
    Neoplasia; 2003; 5(5):427-36. PubMed ID: 14670180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Transcription regulation of 5-Aza-2'-deoxycytidine on maspin gene demethylation in RKO human colorectal cell line].
    Tang B; Peng ZH; Yu PW; Zeng DZ; Zhang C
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 May; 9(3):260-3. PubMed ID: 16721693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maspin expression is transactivated by p63 and is critical for the modulation of lung cancer progression.
    Kim S; Han J; Kim J; Park C
    Cancer Res; 2004 Oct; 64(19):6900-5. PubMed ID: 15466179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas.
    Ohike N; Maass N; Mundhenke C; Biallek M; Zhang M; Jonat W; Lüttges J; Morohoshi T; Klöppel G; Nagasaki K
    Cancer Lett; 2003 Sep; 199(2):193-200. PubMed ID: 12969792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells.
    Kim TY; Jong HS; Song SH; Dimtchev A; Jeong SJ; Lee JW; Kim TY; Kim NK; Jung M; Bang YJ
    Oncogene; 2003 Jun; 22(25):3943-51. PubMed ID: 12813468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrant maspin expression in human endometrial cancer.
    Murai S; Maesawa C; Masuda T; Sugiyama T
    Cancer Sci; 2006 Sep; 97(9):883-8. PubMed ID: 16822296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
    Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
    Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylation of the thyroid-stimulating hormone receptor gene in epithelial thyroid tumors: a marker of malignancy and a cause of gene silencing.
    Xing M; Usadel H; Cohen Y; Tokumaru Y; Guo Z; Westra WB; Tong BC; Tallini G; Udelsman R; Califano JA; Ladenson PW; Sidransky D
    Cancer Res; 2003 May; 63(9):2316-21. PubMed ID: 12727856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased expression of retinoblastoma protein-interacting zinc-finger gene 1 in human esophageal squamous cell cancer by DNA methylation.
    Dong SW; Cui YT; Zhong RR; Liang DC; Liu YM; Wang YG; He Z; Wang S; Liang SJ; Zhang P
    Clin Lab; 2012; 58(1-2):41-51. PubMed ID: 22372344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The regulation of MASPIN expression in epithelial ovarian cancer: association with p53 status, and MASPIN promoter methylation: a gynecologic oncology group study.
    Alvarez Secord A; Darcy KM; Hutson A; Huang Z; Lee PS; Jewell EL; Havrilesky LJ; Markman M; Muggia F; Murphy SK
    Gynecol Oncol; 2011 Nov; 123(2):314-9. PubMed ID: 21903246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells.
    Liu Z; Zhang L; Ding F; Li J; Guo M; Li W; Wang Y; Yu Z; Zhan Q; Wu M; Liu Z
    Cancer Lett; 2005 Dec; 230(2):271-83. PubMed ID: 16297713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic silencing of TTF-1/NKX2-1 through DNA hypermethylation and histone H3 modulation in thyroid carcinomas.
    Kondo T; Nakazawa T; Ma D; Niu D; Mochizuki K; Kawasaki T; Nakamura N; Yamane T; Kobayashi M; Katoh R
    Lab Invest; 2009 Jul; 89(7):791-9. PubMed ID: 19506552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.